Torben Bjerregaard Larsen

  • Sdr. Skovvej 15

    9000 Aalborg

    Denmark

19992020
If you made any changes in Pure these will be visible here soon.

Activities 2009 2015

Filter
Talks and presentations in private or public companies

To switch (from vitamin-K antagonist to NOAC) or not to switch – that's the question

Torben Bjerregaard Larsen (Lecturer)
25 Sep 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

NOAC: Where are we going?

Torben Bjerregaard Larsen (Lecturer)
25 Sep 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Stroke Prevention and Anticoagulation

Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

The Patient Who Is Elderly, Cognitively Impaired or Falling

Torben Bjerregaard Larsen (Lecturer)
20 Jun 2014

Activity: Talks and presentationsTalks and presentations in private or public companies

Strategies for a better outcome of the TTR and an improved patient compliance

Torben Bjerregaard Larsen (Lecturer)
4 Oct 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Anticoagulation and patient cooperation go hand in hand: The journey to 70 % TTR – How do we get there

Torben Bjerregaard Larsen (Lecturer)
4 Oct 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

A proactive approach to the monitoring of new drugs: PhVWP(h) - Pharmacovigilance Working Party (human)

Torben Bjerregaard Larsen (Lecturer)
26 Apr 2012

Activity: Talks and presentationsTalks and presentations in private or public companies

Comparison of the CHADS2 and CHA2DS2VASc prediction rules for stroke in patients with atrial fibrillation

Torben Bjerregaard Larsen (Lecturer)
29 Aug 2011

Activity: Talks and presentationsTalks and presentations in private or public companies